Phase 1, single ‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia

Journal of Thrombosis and Haemostasis, EarlyView.

Source: Journal of Thrombosis and Haemostasis - August 28, 2018 Category: Hematology Authors: R. A. Gruppo , D. Malan , J. Kapocsi , L. Nemes , C. R. M. Hay , L. Boggio , P. Chowdary , G. Tagariello , A. von Drygalski , F. Hua , M. Scaramozza , S. Arkin , , C. R. J. R. Hermans , C. Claes , I. Hanes , I. Huyghe , Source Type: research